Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e29c0a196e55eb3f0db94799017d5c1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b1c3d42031bad5ab0ae64b261d8e4d1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
filingDate |
2019-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e2d800749c956e7919ccf3cf6d1b843 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0e73ee4b634b304313a5724174ba8b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0fc62e4674d6304d0230a4e71209897 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71c0b02f2aef592ef975cf04f4cc3d36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7d185f0fa5f00d3ae6bb705755fb644 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42ce35290aa6f9b637c8bf3e46fd2763 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5113308b47c93fc2ac06e5986a82e98 |
publicationDate |
2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10960003-B2 |
titleOfInvention |
Pyrazole pyrimidine derivative and uses thereof |
abstract |
The present invention provides pyrazole pyrimidine derivatives which inhibit Casein kinase I (CKI) and/or Interleukin-1 receptor-associated kinase 1 (IRAKI) and methods of their manufacture, compositions comprising them and uses thereof in methods of treating malignant disease and disorders and methods for treating inflammatory diseases and disorders. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020383984-A1 |
priorityDate |
2015-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |